throbber

`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`UNITED STATES DEPARTMENT OF COMMERCE
`United States Patent and Trademark Office
`Address: COMMISSIONER FOR PATENTS
`17.0. Box 1450
`Alexandria, Virginia 22313-1450
`www.usplo.gov
`
`APPLICATION NO.
`
`FILING DATE
`
`FIRST NAMED INVENTOR
`
`ATTORNEY DOCKET NO.
`
`CONFIRMATION NO.
`
`90/009,625
`
`10/28/2009
`
`‘
`
`'6482 I 99
`
`7590
`
`‘
`
`03/12/2010
`
`Joseph Neev c/o
`Y-BEAM TECHNOLOGIES, INC.
`20321 Lake Forest Drive
`Suite D-6
`Lake Forest, CA 92630
`
`'
`
`4434
`
`EXAMINER
`
`,
`
`'
`
`DATE MAILED: 03/12/2010
`
`Please find below and/or attached an Office communication concerning this application or proceeding.
`
`Icovmm‘i'amlmf Elm/m L,FLAA¢E(L
`
`f-‘EQQICQ, SLAKHMQ <1 LAG: BEQMAAIJ LLC
`Owe COMMERCE CCMT‘FQ
`'
`V
`,_. m»
`1.201
`LI OLANQE Swab
`Ilene
`\hg\L—.M\MC9TO.N, ’DQ \OIBQI" 11% lo
`
`CLXTKQ ATWA N (90 NStg
`
`PTO-90C (Rev. 10/03)
`
`Alcon Research, Ltd.
`Exhibit 1007 - Page 1
`
`Alcon Research, Ltd.
`Exhibit 1007 - Page 1
`
`

`

`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`Commissioner for Patents
`United States Patents and Trademark Office
`P.O.Box 1450
`Alexandria, VA 22313-1450
`"
`www.uspto. gov
`
`THIRD PARTY REQUESTER'S CORRESPONDENCE ADDRESS
`
`Date:
`
`Scott Catlin
`
`ABBOTT MEDICAL OPTICS INC.
`
`1700 East St. Andrew Place
`
`Santa Ana, CA 92705
`
`EX PARTE REEXAMINATION COMMUNICATION TRANSMITTAL FORM
`
`REEXAMINATION CONTROL NO. : 90009625
`
`PATENT NO. : 6482199
`
`ART UNIT : 3993
`
`Enclosed is a copy of the latest communication from the United States Patent and Trademark
`Office in the above identified ex parte reexamination proceeding (37 CFR 1.550(f)).
`
`Where this copy is supplied after the reply by requester, 37 CFR 1.535, or the time for filing a
`reply has passed, no submission on behalf of the ex parte reexamination requester will be
`acknowledged or considered (37 CFR 1.550(9)).
`
`Alcon Research, Ltd.
`Exhibit 1007 - Page 2
`
`Alcon Research, Ltd.
`Exhibit 1007 - Page 2
`
`

`

`
`
`Control No.
`90/009,625
`
`Patent Under Reexamination
`6482199
`
`Art Unit
`3993
`
`
`
`Office Action in Ex Parte Reexamination
`Examiner
`BEVERLY M. FLANAGAN
`
`
`
`-- The MAILING DA TE of this communication appears on the cover sheet with the correspondence address --
`
`
`
`
`bl] This action is made FINAL.
`.
`alj Responsive to the communication(s) filed on
`CIXI A statement under 37 CFR 1.530 has not been received from the patent owner.
`
`
`A shortened statutory period for response to this action is set to expire g month(s) from the mailing date of this letter.
`Failure to respond within the period for response will result in termination of the proceeding and issuance of an ex parte reexamination »
`
`certificate in accordance with this action. 37 CFR 1.550(d). EXTENSIONS OF TIME ARE GOVERNED BY 37 CFR 1.550(c).
`
`If the period for response specified above is less than thirty (30) days, a response within the statutory minimum of thirty (30) days
`will be considered timely.
`
`
`
`
`
`
`THE FOLLOWING ATTACHMENT(S) ARE PART OF THIS ACTION:
` 1. El Notice of References Cited by Examiner, PTO—892.
`3. E]
`Interview Summary, PTO-474.
`
`
`2. E]
`Information Disclosure Statement, PTO/88708.
`'4.
`[:1
`
`
`Part II
`SUMMARY OF ACTION
`
`
`
`Claims 1 and 2 are subject to reexamination.
`
`
`IZI
`Claims 3-16 are not subject to reexamination.
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Part I
`
`D E
`
`Claims
`
`have been canceled in the present reexamination proceeding.
`
`] Claims __ are patentable and/or confirmed.
`
`has been (7a)l:| approved (7b)I:I disapproved.
`
`Claims 1 and 2 are rejected.
`
`Claims
`
`are objected to.
`
`E I
`
`II
`
`[:I The drawings, filed on
`are acceptable.
`E] The proposed drawing correction, filed on
`
`[:1 Acknowledgment is made of the priority claim under 35 U.S.C. § 119(a)-(d)‘or (f).
`
`a)[:l All b)l:I Some* c)EI None
`
`of the certified copies have
`
`1:] been received.
`
`2E] . not been received.
`
`3D been filed in Application No.
`
`4:] been filed in reexamination Control No.
`
`5|:I been received by the International Bureau in PCT application No.
`* See the attached detailed Office action for a list of the certified copies not received.
`
`9. I] Since the proceeding appears to beIn condition forIssuance of an ex parte reexamination certificate except for formal
`matters, prosecution as to the merits Is closedIn accordance with the practice under Ex parte Quayle, 1935 C. D.
`
`11, 453 O G. 213
` 10. C] Other:
`
`US. Patent and Trademark Office
`
`PTOL-466 (Rev. 08-06)
`
`V
`
`'
`
`Office Action in Ex Parte Reexamination
`
`Part of Paper No. --
`Alcon Research, Ltd.
`Exhibit 1007-Page 3
`
`Alcon Research, Ltd.
`Exhibit 1007 - Page 3
`
`

`

`
`
`Application/Control Number: 90/009,625
`
`‘
`
`Page 2
`
`Art Unit: 3993
`
`DETAILEO ACTION
`
`Reexamination Procedures
`
`In order to ensure full consideration of any amendments, affidavits or
`
`declarations, or other documents as evidence of patentability, such documents must be
`
`submitted in response to this Office action. Submissions after the next Office action,
`
`which is intended to be a final action, will be governed by the requirements of 37 C.F.R.
`
`1.116, after final rejection and 37 C.F.R. 41.33 after appeal, which will be strictly
`
`enforced.
`
`Extensions of time under 37 C.F.R. 1.136(a) will not be permitted in these
`
`proceedings because the provisions of 37 C.F.R. 1.136 apply only to “an applicant" and
`
`not to parties in a reexamination proceeding. Additionally, 35 U.S.C. § 305 requires that
`
`reexamination proceedings “will be conducted with special dispatch” (37 C.F.R.
`
`1.550(a)). Extension of time in ex parte reexamination proceedings are provided for in
`
`‘
`37 C.F.R. 1.550(0).
`The patent owner is reminded‘of the continuing responsibility under 37 C.F.R.
`
`1.565(a) to apprise the Office of any litigation activity, or other prior or concurrent
`
`proceeding, involving Patent No. 6,482,199 throughout the course of this reexamination
`
`proceeding. The third party requester is also reminded of the ability of similarly apprise
`
`the Office of any such activity or proceeding throughout the course of this reexamination
`
`proceeding. See MPEP §§ 2207, 2282 and 2286.
`
`Patent owner is notified that any proposed amendment to the specification and/or
`
`claims in this reexamination proceeding must comply with 37 C.F.R. 1.530(d)-(j), must
`
`Alcon Research, Ltd.
`Exhibit 1007 - Page 4
`
`Alcon Research, Ltd.
`Exhibit 1007 - Page 4
`
`

`

`Application/Control Number: 90/009,625
`Art Unit: 3993
`
`Page 3
`
`be formally presented pursuant to 37 C.F.R. 1.52(a) and (b), and must contain any fees
`
`required by 37 C.F.R. 1.20(c).
`
`After the filing of a request for reexamination by a third party requester, any
`
`document filed by either the patent owner or the third party requested must be served
`
`on the other party (or parties where two or more third party requested proceedings are
`
`merged) in the reexamination proceeding in the manner provided in 37 C.F.R. 1.248.
`
`See 37 C.F.R. 1.550(r).
`
`Patent Owner’s Statement
`
`No timely patent owner’s statement has been filed.
`
`Claim Rejections - 35 USC § 102
`
`The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that
`
`form the basis for the rejections under this section made in this Office action:
`
`' A person shall be entitled to a patent unless -
`
`(b) the invention was patented or described in a printed publication in this or a foreign country or in public
`use or on sale in this country, more than one year prior to the date of application for patent in the United
`States.
`
`Claims 1 and 2 are rejected under 35 U.S.C. 102(b) as being anticipated by Bille.
`
`In regard to claims 1 and 2, Bille teaches a method for varying the volumetric
`
`power density of the laser to vary the rate of material modification from zero, through a
`transition range of tissue modification, to complete ablation (see col. 3, lines 50-54 and
`
`col. 7, lines 28-46). Bille also teaches, through the recitation of a “quasi-continuous
`
`laser beam” a pulsed laser that emits a continuous stream of discrete pulses. For
`
`Alcon Research, Ltd.
`Exhibit 1007 - Page 5
`
`Alcon Research, Ltd.
`Exhibit 1007 - Page 5
`
`

`

`Application/Control Number: 90/009,625
`
`'
`
`Page 4
`
`Art Unit: 3993
`
`example, Fig. 1A shows two “emissions” (pulses) in a string of more that 10,000
`
`emissions per second where each emission has a peak energy intensity of 10
`
`megawatts and a duration 14 as short as 1 picosecond (see col. 4, lines 49-64).
`
`Between the emissions-is a quiescent period 17, which is substantially and significantly
`
`larger than duration 14 (see col. 4, lines 49-64). Bille also teaches that, by adjusting the
`
`laser parameters, one can very the volumetric power density of each pulse from a very
`
`low level up to the point where the volumetric power density exceeds a threshold at
`
`which the tissue is modified and beyond, to a threshold at which the tissue is ablated
`
`(see col. 7,» lines 28-46). Bille teaches that the volumetric power density may be varied
`
`by changing the beam intensity, by altering the focus and therefore, the spot size, or by
`
`changing the pulse duration (see col. 5, line 62 through col. 6, line 5). Bille also teaches
`
`that the beam intensity can be changed during the operation of the pulse source in
`
`internal ablation procedures (see col. 6, lines 5-8). Bille also teaches material
`modification in the form of water evaporated from the tissue and intermolecular bonds
`
`are broken to change the visco-elastic properties of the material (photoablation) (see
`
`col. 8, lines 35-37), which equates to at least two different forms of material
`
`modification: ablation and alteration of viscoelastic properties (see also col. 6, lines 31-
`
`43). Bille also teaches an interval between pulses that is long enough .to allow
`
`interaction energy transients caused by the electromagnetic radiation pulse to
`
`substantially decay so that material modification is effected (see page 31 of the request,
`
`detailing the disclosure of Bille and pointing out that the down time between pulses is
`
`about 100 times longer than that taught by US. Patent No. 6,482,199). Bille also
`
`Alcon Research, Ltd.
`Exhibit 1007 - Page 6
`
`Alcon Research, Ltd.
`Exhibit 1007 - Page 6
`
`

`

`Application/Control Number: 90/009,625
`
`Page 5
`
`Art Unit: 3993
`
`’
`
`teaches a repetition rate of 10,000 repetitions per second (see col. 5, lines 8-10). Bille
`
`also teaches focusing the beam at a particular depth below the surface, so as to
`
`achieve the desired volumetric power density at that point (see col. 6, lines 5-8).
`
`In
`
`order for the light to reach that depth, the wavelength of the incident light must be
`
`matched to the material such that the material is substantially transparent to the linear
`
`propagation of light. Near-infra red light applied to biological tissue, Such as the cornea,
`
`--is an example (see col. 10, lines 30-45).
`
`Claim 1 is rejected under 35 U.S.C. 102(b) as being anticipated by Niemz.
`
`Niemz teaches ablating the cornea in a controlled manner with a pulsed laser, by
`
`placing 50 lines, one of top of the other, in order to ablate for depth and working with a
`
`spot size that allowed two spots to be situated only 15 microns apart (see page 428).
`
`The depth of ablation resulting is a direct function of the radiation energy, allowing
`
`controlled an predictable ablation (material modification) (see page 430). The
`
`operational parameters of the laser are such that the power absorbed by the cornea
`exceeds the "plasma threshold" (see page 426). Niemz teaches a pulsed laser that
`
`generated an output of pulses having a width or duration of about 60 picoseconds (see
`
`page 427). Niemz teaches that, to obtain the desired plasma-mediated interation, one
`must increase the energy density until visible sparking, indicating formation of a plasma,
`
`occurs (see pages 426-428). Niemz teaches that the combination of low pulse energy,
`
`picosecond pulse widths and small minimum spot size provides an extremely high peak
`
`power density of 10 12W/cm2, and fluence of 100 J/cmz, which exceeds the
`
`Alcon Research, Ltd.
`Exhibit 1007 - Page 7
`
`Alcon Research, Ltd.
`Exhibit 1007 - Page 7
`
`

`

`Application/Control Number: 90/009,625
`
`Page6
`
`Art Unit: 3993
`
`'
`
`requirements to achieve plasma-mediated ablation (see pages 426—428). Niemz
`
`teaches that the rapid expansion of the plasma causes a shock wave (see page 430).
`
`Niemz provides several photographs of the modified material. Niemz also teaches a
`
`pulse repetition rate of 1kHz or 1000 pulses per second (see page 427).
`
`Claims 1 and 2 are rejected under 35 U.S.C. 102(b) as being anticipated by
`
`Juhasz.
`
`In regard to claims 1 and 2, Juhasz teaches ablating the cornea in a controlled
`
`manner with a laser where the beam is focused down to a 5 uM spot, the energy per
`
`pulse is variable and the pulse repetition rate is controlled within a range (see pages 24—
`
`25). The operational parameters of the laser are such that the power absorbed by the
`
`cornea exceeds a threshold at which cavitation bubbles are observed, which are
`
`associated with plasma formation and photodisruption forms (see page 25). Juhasz
`
`teaches working with a pulse laser that generated an output of pulses having a width or
`
`duration of about 150 femtoseconds (see page 24). Juhasz also teaches that the
`
`interaction energy transients that take the form of a shock wave with decay as it loses
`energy, until it becomes harmless (see page 27). Juhasz teaches that to ensure decay,
`
`avoiding overlaying two pulses is avoided (see page 30). Juhasz also teaches a pulse
`
`repetition rate of between 25 Hz and 1 kHz. Furthermore, since cavitation bubbles area
`
`below some layers or portion of the cornea, the corneal tissue must at least be in part
`
`transparent to linear beam propagation (see page 29).
`
`Alcon Research, Ltd.
`Exhibit 1007 - Page 8
`
`Alcon Research, Ltd.
`Exhibit 1007 - Page 8
`
`

`

`Application/Control Number: 90/009,625
`
`Page 7
`
`Art Unit: 3993
`
`Claim Rejections - 35 USC § 103
`
`The following is a quotation of 35 U.S.C. 103(a) which forms the basis for all
`
`obviousness rejections set forth in this Office action:
`
`(a) A patent may not be obtained though the invention is not identically disclosed or described as set
`forth in section 102 of this title, if the differences between the subject matter sought to be patented and
`the prior art are such that the subject matter as a whole would have been obvious at the time the
`invention was made to a person having ordinary skill in the art to which said subject matter pertains.
`Patentability shall not be negatived by the manner in which the invention was made.
`
`Claims 1 and 2 are rejected under 35 U.S.C. 103(a) as being unpatentable over
`
`Jacques in view of Bille.
`
`Inregard to claims 1 and 2, Jacques teaches several different types of material
`
`modification, including photochemical ablation, photothermal ablation and
`
`photomechanical ablation, as well as non-ablative modifications of tissue such as
`
`coagulation, using pulsed lasers having pulse durations ranging between the low
`
`picoseconds and ten milliseconds (see Fig. 13 and page 555). Jacques also teaches
`
`laser having an output beam made up of a series of pulses of laser light, the pulse
`
`widths varying from 100 femtoseconds to 500 milliseconds (see page 536). Jacques
`
`also teaches that, to obtain a desired laser-tissue effect, one must turn up the laser
`
`power (intensity) until, at some “threshold laser exposure", the effect is achieved (see
`
`page 531). Jacques also discloses the importance of the combination of fluence
`
`(energy over a particular surface area) and depth of penetration in determining ablation
`
`(see page 541). Jacques also teaches that at a certain energy level, photochemical
`ablation will occur (see page 543). Jacques also teaches the photomechanical effects
`of laser-tissue interaction, such as ablation at the surface or cellular damage within the
`
`tissue and photochemical effects , such as cross-linking and oxidative injury (see page
`
`Alcon Research, Ltd.
`Exhibit 1007 - Page 9
`
`Alcon Research, Ltd.
`Exhibit 1007 - Page 9
`
`

`

`Application/Control Number: 90/009,625
`
`Page 8
`
`Art Unit: 3993
`
`'
`
`‘
`
`550).
`
`Jacques is not directed at operating specifics of the laser. However, Bille
`
`discloses that, by adjusting the laser parameters, one can very the volumetric power
`
`density of each pulse from a very low level up to the point where the volumetric power
`
`density exceeds a threshold at which the tissue is modified and beyond, to a threshold
`
`at which the tissue is ablated (see col. 7, lines 28-46). Bille teaches that the volumetric
`
`power density may be varied by changing the beam intensity, by altering the focus and
`
`therefore, the spot size, or by changing the pulse duration (see col. 5, line 62 through
`
`col. 6, line 5). Bille also teaches that the beam intensity can be changed during the
`
`operation of the pulse source in internal ablation procedures (see col. 6, lines 5-8). Bille
`
`also teaches material modification in the form of water evaporated from the tissue and
`
`intermolecular bonds are broken to change the visco-elastic properties of the material
`
`(photoablation) (see col. 8, lines 35-37), which equates to at least two different forms of
`
`material modification: ablation and alteration of viscoelastic properties (see also col. 6,
`
`lines 31-43). Bille also teaches an interval between pulses that is long enough to allow
`interaction energy transients caused by the electromagnetic radiation pulse to
`
`I
`
`substantially decay so that material modification is effected (see page 31 of the request,
`
`detailing the disclosure of Bille and pointing out that the down time between pUlses is
`
`about 100 times longer than that taught by US. Patent No. 6,482,199). Bille also
`
`teaches a repetition rate of 10,000 repetitions per second (see col. 5, lines 8-10). Bille
`
`also teaches focusing the beam at a particular depth below the surface, so as to
`
`achieve the desired volumetric power density at that point (see col. 6, lines 5-8).
`
`In
`
`order for the light to reach that depth, the wavelength of the incident light must be
`
`Alcon Research, Ltd.
`Exhibit 1007 - Page 10
`
`Alcon Research, Ltd.
`Exhibit 1007 - Page 10
`
`

`

`Application/Control Number: 90/009,625
`
`Art Unit: 3993
`
`Page 9
`
`‘ matched to the material such that the material is substantially transparent to the linear
`
`propagation of light. Near-infra red light applied to biological tissue, such as the cornea,
`
`is an example (see col. 10, lines 30-45). As Bille teaches a similar device and method
`
`and, as such, one of ordinary skill in the art would be motivated to turn to Bille to teach
`
`the operating parameters of the laser and to apply'these applications to Jacques.
`
`Scope of Reexamination
`
`Since requester did not request reexamination of claims 3-16 and did not assert
`
`the existence of a substantial new question of patentability (SNQP) for such claims
`
`(see 35 U.S.C. § 311(b)(2); see also 37 CFR 1.915b and 1.923), such claims will not be
`
`reexamined. This matter was squarely addressed in Sony Computer Entertainment
`
`America Inc., et al. v. Jon W Dudas, Civil Action No. 1:050V1447.(E.D.Va. May 22,
`
`2006), Slip Copy, 2006 WL 1472462.
`
`(Not Reported in F.Supp.2d.) The District Court
`
`upheld the Office's discretion to not reexamine claims in an inter partes reexamination
`
`proceeding other than those claims for which reexamination had specifically been
`
`requested. The Court stated:
`
`To be sure, a party may seek, and the PTO may grant, inter
`partes review of each and every claim of a patent. Moreover,
`while the PTO in its discretion may review claims fOr which inter
`partesreview was not requested, nothing in the statute compels
`it to do so. To ensure that the PTO considers a claim for inter
`partes review, § 311(b)(2)
`requires that
`the party seeking
`reexamination demonstrate why the PTO should reexamine
`each and every claim for which it seeks review. Here,
`it
`is
`undisputed that Sony did not seek review of every claim under
`the '213 and '333 patents. Accordingly, Sony cannot now claim
`that the PTO wrongly failed to reexamine claims for which Sony
`
`Alcon Research, Ltd.
`Exhibit 1007 - Page 11
`
`Alcon Research, Ltd.
`Exhibit 1007 - Page 11
`
`

`

`Application/Control Number: 90/009,625
`
`Page 10
`
`Art Unit: 3993
`
`never requested review, and its argument that AIPA compels a
`contrary result is unpersuasive.
`
`(Slip copy at page 9.)
`
`The Sony decision’s reasoning and statutory interpretation apply analogously to
`
`ex parte reexamination, as the same relevant statutory language applies to both inter
`
`partes and ex parte reexamination. 35 U.S.C. § 302 provides that the ex parte
`
`reexamination “request must set forth the pertinency and manner of applying cited prior
`
`art to evem claim for which reexamination is regueste " (emphasis: added), and 35
`U.S.C. § 303 provides that “the Director will determine whether a substantial new I
`
`question of patentability affecting any claim of the patent concerned is raised by the
`
`Lem...” (Emphasis added). These provisions are analogous to the language of 35
`
`U.S.C. § 311(b)(2) and 35 U.S.C. § 312 applied and construed in Sony, and would be
`
`. construed in the same manner. As the Director can decline to reexamine nbn-
`
`requested claims in an inter partes reexamination proceeding, the Director can likewise
`
`do so in ex parte reexamination proceeding. S_e§ Notice of Clarification of Office Policy
`
`To Exercise'Discretion in Reexamining Fewer Than All the Patent Claims (signed Oct.
`
`5, 2006) 1311 0G 197 (Oct. 31, 2006). fiaisg MPEP § 2240, Rev. 5, Aug. 2006.
`
`4
`
`Therefore, claims 3-16 will not be reexamined in this inter partes reexamination
`
`proceeding.
`
`' Alcon Research, Ltd.
`Exhibit 1007 - Page 12
`
`Alcon Research, Ltd.
`Exhibit 1007 - Page 12
`
`

`

`Application/Control Number: 90/009,625
`Art Unit: 3993
`
`Page 11
`
`Please mail any communications to:
`
`Conclusion
`
`Attn: Mail Stop “Ex Parte Reexam"
`Central Reexamination Unit
`
`Commissioner for Patents
`P.O. Box1450 ‘
`
`Alexandria, VA 22313-1450
`
`Please FAX any communications to:
`
`(571) 273-9900
`Central Reexamination Unit
`
`Please hand-deliver any communications to:
`
`Customer Service Window
`
`Attn: Central Reexamination Unit
`
`Randolph Building, Lobby Level
`401 Dulaney Street
`Alexandria, VA 22314
`
`Any inquiry concerning this communication or earlier communications from the
`Examiner, or as to the status of this proceeding, should be directed to the Central.
`Reexamination Unit at'telephone number (571) 272-7705.
`
`Signed:
`
`IBeverly M. Flanagan/
`
`Beverly M. Flanagan
`CRU Examiner
`
`GAU 3993
`
`(571) 272-4766
`
`Conferee:/J RJ/
`
`Conferee:
`
`fl
`
`Alcon Research, Ltd.
`Exhibit 1007 - Page 13
`
`Alcon Research, Ltd.
`Exhibit 1007 - Page 13
`
`

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket